Structure-activity relationships of amino glyco side-arginine conjugates that bind HIV-1 RNAs as determined by fluorescence and NMR spectroscopy

被引:31
作者
Lapidot, A [1 ]
Vijayabaskar, V
Litovchick, A
Yu, JG
James, TL
机构
[1] Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel
[2] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA
关键词
aminoglycoside-arginine conjugate; HIV-1; TAR; RRE RNA; fluorescence anisotropy; 2D-TOCSY NMR TAR-NeoR1;
D O I
10.1016/j.febslet.2004.10.038
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We present here a new set of aminoglycoside-arginine conjugates (AACs) that are either site-specific or per-arginine conjugates of paromomycin, neamine, and neomycin B as well as their structure-activity relationships. Their binding constants (K-D) for TAR and RRE RNAs, measured by fluorescence anisotropy, revealed dependence on the number and location of arginines in the different aminoglycoside conjugates. The binding affinity of the per-arginine aminoglycosides to TAR is higher than to RRE, and hexa-arginine neomycin B is the most potent binder (KD = 5 and 23 nM, respectively). The 2D TOCSY NMR spectrum of the TAR monoarginine-neomycin complex reveals binding at the bulge region of TAR. (C) 2004 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:415 / 421
页数:7
相关论文
共 40 条
[1]   HIV-1 REV REGULATION INVOLVES RECOGNITION OF NON-WATSON-CRICK BASE-PAIRS IN VIRAL-RNA [J].
BARTEL, DP ;
ZAPP, ML ;
GREEN, MR ;
SZOSTAK, JW .
CELL, 1991, 67 (03) :529-536
[2]   Mutations in gp41 and gp120 of HIV-1 isolates resistant to hexa-arginine neomycin B conjugate [J].
Borkow, G ;
Lara, HH ;
Lapidot, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 312 (04) :1047-1052
[3]   Structure-activity relationship of neomycin, paromomycin, and neamine-arginine conjugates, targeting HIV-1 gp120-CXCR4 binding step [J].
Borkow, G ;
Vijayabaskar, V ;
Lara, HH ;
Kalinkovich, A ;
Lapidot, A .
ANTIVIRAL RESEARCH, 2003, 60 (03) :181-192
[4]   Solution structure of the HIV-2 TAR-argininamide complex [J].
Brodsky, AS ;
Williamson, JR .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 267 (03) :624-639
[5]   Anti-human immunodeficiency virus activity of novel aminoglycoside-arginine conjugates at early stages of infection [J].
Cabrera, C ;
Gutiérrez, A ;
Blanco, J ;
Barretina, J ;
Litovchick, A ;
Lapidot, A ;
Evdokimov, AG ;
Clotet, B ;
Esté, JA .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (07) :627-634
[6]   Anti-HIV activity of a novel aminoglycoside-arginine conjugate [J].
Cabrera, C ;
Gutiérrez, A ;
Barretina, J ;
Blanco, J ;
Litovchick, A ;
Lapidot, A ;
Clotet, B ;
Esté, JA .
ANTIVIRAL RESEARCH, 2002, 53 (01) :1-8
[7]   ARGININE-MEDIATED RNA RECOGNITION - THE ARGININE FORK [J].
CALNAN, BJ ;
TIDOR, B ;
BIANCALANA, S ;
HUDSON, D ;
FRANKEL, AD .
SCIENCE, 1991, 252 (5009) :1167-1171
[8]   Inhibition of protein synthesis by aminoglycoside-arginine conjugates [J].
Carriere, M ;
Vijayabaskar, V ;
Applefield, D ;
Harvey, I ;
Garneau, P ;
Lorsch, J ;
Lapidot, A ;
Pelletier, J .
RNA, 2002, 8 (10) :1267-1279
[9]   The Tat antagonist neomycin B hexa-arginine conjugate inhibits gp-120-induced death of human neuroblastoma cells [J].
Catani, MV ;
Corasaniti, MT ;
Ranalli, M ;
Amantea, D ;
Litovchick, A ;
Lapidot, A ;
Melino, G .
JOURNAL OF NEUROCHEMISTRY, 2003, 84 (06) :1237-1245
[10]   Design of RNA-binding proteins and ligands [J].
Cheng, AC ;
Calabro, V ;
Frankel, AD .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 2001, 11 (04) :478-484